Speeding Time to Market Cost-Effectively
With the recent news of pharma’s frustration with more price controls around the world, John Avellanet, frequent Biotech Blog poster […]
With the recent news of pharma’s frustration with more price controls around the world, John Avellanet, frequent Biotech Blog poster […]
This is a student paper from the 2010 final projects in the NIH Foundation for Advanced Education in the Sciences’
Profitability and Orphans: The Role of Price and Incentives in Four Different Markets Read Post »
Now available: a book by frequent BiotechBlog contributor, John Avellanet. In this new book — Get to Market Now! Turn
Coming soon, a book by frequent BiotechBlog contributor, John Avellanet. In this new book — Get to Market Now! Turn
At a recent event on the comparative advantages of small molecule vs. biologic drugs, several themes emerged which led me
Is the practice of medicine impeding medical innovation? Read Post »
In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s
In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s